Provider
QP68-18 Site of Care Drug Infusion/Injection Program
Program effective Date: Aug 21, 2018
Documents & Forms Results
Displaying 2741 - 2750 of 3102 results
Provider
QP67-18 Pharmacy Benefit Exclusion for Alferon N (interferon alpha-n3), Cytovene (ganciclovir), Foscarvir (foscarnet), Prevymis (letermovir), Trogarzo (ibalizu,ab-uiyk), Vistide (cidofovir) and Zovirax (actclovir)
Program effective Date: Aug 21, 2018
Provider
QP72-18 Pharmacy Benefit Update - New Drug-Related Step Therapy with Quantity Limit Criteria: Dipeptidyl Peptidase - 4 (DPP-4) Inhibitors
Program effective Date: Aug 21, 2018
Provider
QP64-18 Action Required: Apply for Designation as a Blue Distinction Center for Spine Surgery
Program effective Date: Aug 14, 2018
Provider
QP63-18 Action Required: Apply for Designation as a Blue Distinction Center for Knee and Hip Replacement
Program effective Date: Aug 14, 2018
Provider
QP62-18 2018 Fall Blue Cross Basic Seminars to Include Availity Portal Training
Program effective Date: Aug 14, 2018
Provider
QP61-18 Availity Authorization Training with Live Demo
Program effective Date: Aug 06, 2018
Provider
QP60-18 Update: Change to Call Center for Transportation for MHCP Members
Program effective Date: Aug 01, 2018
Provider
P34-18 Clarification to MAPD PA Requirements for Hereditary Angioedema (HAE) Medical Drugs
Program effective Date: Aug 01, 2018
Provider
P32-18 New Requirements for Medicare and Medicaid Providers
Program effective Date: Aug 01, 2018